Cure Alzheimer’s Fund is a not-for-profit research funder. Our focused mission is to accelerate the development of scientific knowledge that will yield disease-modifying benefit to potential and current Alzheimer’s patients. Located in Wellesley Hills, Massachusetts, we are a 31-person organization that seeks to make an impact disproportionate to our size.
The CureAlz Research Management team partners with the scientific community and, alongside our Development and Marketing/Communications colleagues, our generous donor community. All assessment of scientific projects is performed by our external scientific affiliates, leading researchers actively pursuing cutting-edge science across a wide range of subspecialties. Our internal Research Management team ensures that our portfolio of funded projects meets our mission goals, that our external scientific leadership has the right information to make the best possible decisions, and that our lay community is kept well informed of what we are supporting and why it matters.
CureAlz seeks to add a VP for Research Management. The new team member will:
Help manage all aspects of the research funding process: PI/project identification and recruitment, matching of reviewers and projects and facilitation of the review process, management of the reporting process, and communication of results within the broader CureAlz and Alzheimer’s disease (AD) scientific contexts;
Stay current with new scientific findings and publications about AD and related areas;
Work closely with external scientists as applicants, reviewers, decision makers, and direction setters; and
Work closely with internal colleagues in finance and administration (ensuring grant funding works smoothly); development (speaking with donors and coordinating scientist/donor contacts); and marketing and communications (communicating the findings, value, and power of the research we support).
The ideal candidate will have:
A PhD (preferred), in a specialty relevant to neurodegenerative disease;
Recent experience in an academic neuroscience research laboratory setting and with new scientific technologies and approaches;
Strong intellectual curiosity and flexibility, with an ability to think broadly across disparate areas of scientific development;
Demonstrated ability to communicate complex information clearly and accessibly to a wide range of audiences both verbally and in writing;
High standards for accuracy of both gist and details of their work product;
Capacity to travel on an occasional, planned basis, primarily to scientific conferences;
Commitment to working supportively and cooperatively across CureAlz;
Strengths in self-management and organization;
Comfort with remote/distance professional relationship building and collaboration;
Enthusiasm to accelerate the science vital to finding effective treatments and a cure for AD; and
Compassion and empathy for those facing the impact of AD.
Cure Alzheimer’s Fund:
The Cure Alzheimer’s Fund team is comprised of mission-driven professionals who share a commitment to finding a cure. With 31 staff and more than 235 funded researchers around the world, Cure Alzheimer’s Fund has distributed more than $150,000,000 to Alzheimer’s research, with many projects resulting in breakthroughs that provide a deeper understanding of Alzheimer’s disease to get closer to a cure.
There are currently 6 million people in the United States and 50 million worldwide who have been diagnosed with Alzheimer’s disease. Current estimates are that this represents 25% of the actual number of those afflicted; the others have not yet been diagnosed. Underrepresented racial groups and women are most at risk. Of those who have the disease, two-thirds are women. Black Americans are estimated to be twice as likely to get the disease as Caucasian Americans, and the rate of the disease within the Hispanic and Latino populations is expected to grow 7x in the next 30 years.
Recognizing that therapies are only possible when based on successful foundational research, board directors Henry McCance, Jeffrey and Jacqueline Morby, and Phyllis Rappaport formed Cure Alzheimer’s Fund in 2004 with an unwavering focus on providing research grants to the world’s leading scientists researching Alzheimer’s disease. The organization’s vision has been carefully and ambitiously designed to accelerate research, make bold bets, and eradicate Alzheimer’s disease.
The board of directors has also maintained a commitment to the organization itself by covering all operating expenses, ensuring that every dollar raised goes directly to support research initiatives.
Learn more by visiting www.curealz.org.
Alzheimer’s disease affects everyone, from all backgrounds. CureAlz similarly welcomes applications from people of all demographic profiles and backgrounds. We encourage you to apply even if you do not meet 100% of the requirements. All applicants will receive consideration without regard to race, religion, sexual orientation, gender identity, gender expression, age, physical ability, or length of time spent unemployed.
Candidates must be authorized to work in the United States.
Please email a cover letter, resume, and salary requirements to email@example.com.